| 1 | [SID49679873] | Active | IC50 | 1.71 | AlphaScreen confirmatory assay for validation of inhibitors of SUMOylation [AID2018, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | IC50 | 1.71 [uM] | | BioAssay | AlphaScreen confirmatory assay for validation of inhibitors of SUMOylation | | AID | 2018 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 2 | [SID49679873] | Active | Potency | 2.8184 | CHOP2 Reporter Counterscreen Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID493169, Type: confirmatory] | enteropeptidase precursor [Homo sapiens] [gi:223942069] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | CHOP2 Reporter Counterscreen Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 493169 | | BioAssay type | confirmatory | | Target | enteropeptidase precursor [Homo sapiens] [gi:223942069] | | PubMed | | | Data Table |  |
|
| 3 | [SID49679873] | Active | Potency | 3.5481 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 4 | [SID49679873] | Active | Potency | 3.5481 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 5 | [SID49679873] | Active | Potency | 3.5481 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 6 | [SID49679873] | Active | Potency | 3.5481 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 7 | [SID49679873] | Active | Potency | 4.1052 | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen [AID686980, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 4.1052 [uM] | | BioAssay | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen | | AID | 686980 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 8 | [SID49679873] | Active | Potency | 4.4668 | Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a [AID493170, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a | | AID | 493170 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 9 | [SID49679873] | Active | Potency | 4.4668 | Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a [AID493170, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a | | AID | 493170 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 10 | [SID49679873] | Active | Potency | 4.7755 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 4.7755 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 11 | [SID49679873] | Active | IC50 | 4.815 | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) [AID2012, Type: confirmatory] | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | IC50 | 4.815 [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) | | AID | 2012 | | BioAssay type | confirmatory | | Target | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] | | PubMed | | | Data Table |  |
|
| 12 | [SID49679873] | Active | Potency | 11.2202 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 13 | [SID49679873] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 14 | [SID49679873] | Active | Potency | 19.9526 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 15 | [SID49679873] | Active | IC50 | 37.1 | uHTS HTRF assay for identification of inhibitors of SUMOylation [AID2006, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | IC50 | 37.1 [uM] | | BioAssay | uHTS HTRF assay for identification of inhibitors of SUMOylation | | AID | 2006 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 16 | [SID49679873] | Active | EC50 | 37.2 | Dose Response concentration confirmation of uHTS hits from a small molecule activators of mouse intestinal alkaline phosphatase via a luminescent assay [AID488783, Type: confirmatory] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | EC50 | 37.2 [uM] | | BioAssay | Dose Response concentration confirmation of uHTS hits from a small molecule activators of mouse intestinal alkaline phosphatase via a luminescent assay | | AID | 488783 | | BioAssay type | confirmatory | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 17 | [SID49679873] | Active | Potency | 44.6684 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 18 | [SID49679873] | Active | IC50 | 46 | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) [AID2014, Type: confirmatory] | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | IC50 | 46 [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) | | AID | 2014 | | BioAssay type | confirmatory | | Target | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] | | PubMed | | | Data Table |  |
|
| 19 | [SID49679873] | Active | EC50 | 47.8 | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. [AID488880, Type: confirmatory] | alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor [Homo sapiens] [gi:116734717] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | EC50 | 47.8 [uM] | | BioAssay | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. | | AID | 488880 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor [Homo sapiens] [gi:116734717] | | PubMed | | | Data Table |  |
|
| 20 | [SID49679873] | Active | EC50 | 47.8 | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. [AID488880, Type: confirmatory] | alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor [Homo sapiens] [gi:116734717] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | EC50 | 47.8 [uM] | | BioAssay | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. | | AID | 488880 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor [Homo sapiens] [gi:116734717] | | PubMed | | | Data Table |  |
|
| 21 | [SID49679873] | Active | EC50 | 49.7 | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase [AID488878, Type: confirmatory] | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | EC50 | 49.7 [uM] | | BioAssay | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase | | AID | 488878 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] | | PubMed | | | Data Table |  |
|
| 22 | [SID49679873] | Active | EC50 | 49.7 | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase [AID488878, Type: confirmatory] | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | EC50 | 49.7 [uM] | | BioAssay | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase | | AID | 488878 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] | | PubMed | | | Data Table |  |
|
| 23 | [SID49679873] | Active | EC50 | 66 | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Human Intestinal Alkaline Phosphatase [AID488873, Type: confirmatory] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | EC50 | 66 [uM] | | BioAssay | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Human Intestinal Alkaline Phosphatase | | AID | 488873 | | BioAssay type | confirmatory | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 24 | [SID49679873] | Active | EC50 | 66 | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Human Intestinal Alkaline Phosphatase [AID488873, Type: confirmatory] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | EC50 | 66 [uM] | | BioAssay | Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Human Intestinal Alkaline Phosphatase | | AID | 488873 | | BioAssay type | confirmatory | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 25 | [SID49679873] | Active | Potency | 79.4328 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 26 | [SID49679873] | Active | | | uHTS identification of inhibitors of NadD in a Colorimetric assay [AID602399, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of NadD in a Colorimetric assay | | AID | 602399 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 27 | [SID49679873] | Active | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID1822, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 1822 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 28 | [SID49679873] | Active | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID1822, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 1822 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 29 | [SID49679873] | Active | | | QFRET-based biochemical high throughput confirmation assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID2170, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | QFRET-based biochemical high throughput confirmation assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 2170 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 30 | [SID49679873] | Active | | | QFRET-based biochemical high throughput confirmation assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID2170, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | QFRET-based biochemical high throughput confirmation assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 2170 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 31 | [SID49679873] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). [AID2130, Type: screening] | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). | | AID | 2130 | | BioAssay type | screening | | Target | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] | | PubMed | | | Data Table |  |
|
| 32 | [SID49679873] | Active | | | Single concentration confirmation of uHTS hits from a small molecule inhibitors of mouse intestinal alkaline phosphatase via a luminescent assay [AID434971, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits from a small molecule inhibitors of mouse intestinal alkaline phosphatase via a luminescent assay | | AID | 434971 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 33 | [SID49679873] | Active | | | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase [AID2806, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase | | AID | 2806 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 34 | [SID49679873] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 35 | [SID49679873] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 36 | [SID49679873] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 37 | [SID49679873] | Active | | | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). [AID2235, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). | | AID | 2235 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 38 | [SID49679873] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 39 | [SID49679873] | Active | | | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID652036, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 652036 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 40 | [SID49679873] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 41 | [SID49679873] | Active | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 42 | [SID49679873] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 43 | [SID49679873] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 44 | [SID49679873] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 45 | [SID49679873] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 46 | [SID49679873] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 47 | [SID49679873] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 48 | [SID49679873] | Active | | | RNA aptamer-based HTS for inhibitors of GRK2 [AID488847, Type: screening] | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | RNA aptamer-based HTS for inhibitors of GRK2 | | AID | 488847 | | BioAssay type | screening | | Target | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] | | PubMed | | | Data Table |  |
|
| 49 | [SID49679873] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 50 | [SID49679873] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49679873 | | CID | 24762085 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|